Navigation Links
Gardasil Demonstrates Up to 100% Efficacy

rved in the placebo group compared to the one case of CIN3 observed in the vaccine group. ,c)

The one case of CIN3 in the vaccine group of FUTURE II involved a woman who had an infection with Human Papillomavirus type 52 at baseline and at five follow-up visits. Type16 was detected in only one of these visits suggesting that this case could have been type 52-related. To be conservative, this case was nevertheless included in the group that received the vaccine.

CIN2/3 is the obligate precursor of cervical cancer and the clinically most relevant endpoint for the US Food and Drug Administration (FDA) and the World Health Organization (WHO) to demonstrate efficacy in the prevention of cervical cancer.

In both studies, Gardasil® was generally well tolerated. The adverse events observed were similar to what has been previously reported.

Notes to editors

High efficacy has already led to vaccination of women in the placebo groups
In light of the high efficacy shown by Gardasil® at licensure, the Data and Safety Monitoring Board of FUTURE I and II had recommended that women in the placebo group should be vaccinated with Gardasil®. The board recommended that the studies should be terminated as soon as feasible in order to provide the benefits of vaccination with Gardasil® to these women rapidly. In Europe, vaccination of women in the placebo groups of FUTURE I and II has already begun in the United Kingdom, Germany, Sweden, Norway, Denmark, Finland and Austria. In other countries, vaccination will start soon with the objective to complete vaccination before the end of the year 2007. In a similar way, vaccination of women in many other countries around the world, including the US, Australia and Canada, has begun or is anticipated to begin soon.

Protection against additional virus types through cross protection
In large phase III clinical stu
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
2. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gardasil Demonstrates Efficacy
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, MammographyEquipment-AGlobalMarketP...164330/Mammography-Equipment---A-Global-Market-Per...inindustrializedaswellasdevelopingnationsisaprinci...lobally,escalatingawarenessaboutbreastcancerhasall...
(Date:11/25/2009)...ANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc...elopingproductsforminimallydisruptivesurgicaltreat...erencecallonMonday,November30,2009,at5:30p.m.ET/2:...relativetoreimbursementfortheCompany,sproductsandw...estionandanswersession.Thedial-innumbersare1-877-4...
(Date:11/25/2009)...ELFT,TheNetherlandsandJOHANNESBURG,November25/PRNe...dPyxisDiscoveryannouncedtoday,thattheyhavesignedac...,services. , Pyxis,sworldclasscomputationalch...iThemba,sservicedivisiontoprovidemedicinaland,synt...xis,internationalclientnetwork.iThembaPharmaceuti...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Online Banners Yield High Click Through Rate For NAS Texas Healthcare Client 48249 1Online Banners Yield High Click Through Rate For NAS Texas Healthcare Client 48249 2Anesthesia Can Make Patients Vomit After Cosmetic Surgery World 26apos 3Bs Top Expert Says PK Anesthesia Is Better 48247 1Anesthesia Can Make Patients Vomit After Cosmetic Surgery World 26apos 3Bs Top Expert Says PK Anesthesia Is Better 48247 2Anesthesia Can Make Patients Vomit After Cosmetic Surgery World 26apos 3Bs Top Expert Says PK Anesthesia Is Better 48247 3Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 1Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 2Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 3Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 4
...howed 11 Percent Fewer RA Patients,Reported Job Lo...mpared to Methotrexate Alone, BARCELONA, Spain, Ju...rthritis (RA) is one of the most common causes of,... today show that,rheumatoid arthritis (RA) patient...yed working longer, had fewer absences and reporte...
..., 2007 /PRNewswire-FirstCall/ --,Genzyme Corp. tod...ing a powder form of Renvela (sevelamer carbonate)...luding one trial in which,patients received the po... was administered once per day. , Genzyme is devel...nal option for patients with chronic kidney diseas...
Other Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 2Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 3Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 4Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 5
(Date:11/27/2009)...may reduce future disease burden, researchers say ...Encouraging city dwellers to walk and bicycle inst...health benefits than increased used of low-emissio...study compared the projected health effects in 203...r London, England, and Delhi, India: business-as-...
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...te (TM) has been shown in studies to be effective ...ed by an overload of copper, and certain metastati...r, is known about how the drug works at the molecu...versity researchers now has provided an invaluable... to copper-loaded metallochaperones. The drug sequ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...stCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ONXX )...ntsinDecember: ,, ASHBriefing ,, Decem...investigatorswilldiscussdatapresentationssurroundi...loma,asfeaturedatthe51stAmericanSocietyofHematolog...eteleconferencewillbeginat9:00a.m.CT/10:00a.m.ETon...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...o live an exceptional life with depression or bipo...d approach of professional care that addresses you...ship, and career needs that can help you to set re...andard of care in mental health. , ...
...d Boosts Quality through National E-Prescr...July 15 SUMMARY: Today the U.S.,House of Represen...e a,White House veto and pass important Medicare l...tem of national,e-prescribing, and help ensure the...
... http://www.SheKnows.com ) partners with DKMS ... bone marrow donor organization, and Sav...ovanniguglielmo.org ) to promote awareness of ...m/cgi-bin/prnh/20080715/LATU125 ), WHEN: Featu...
...isit by 15% to 19% , , TUESDAY, July 15 (H...atients on Medicare take a companion with them for...ccompanied on such visits tend to be more satisfie... companions on medical visits]," said senior study...
...FirstCall/ -- Genesis,Pharmaceuticals Enterprises,... "Company"), a leading pharmaceutical company in t...t the Company received approval from the,Chinese S... traditional Chinese medicine used to,cure viral i...
...ems HD, LLC,developer of innovative medical device... to a larger space in the Hopper Technology Center... been headquartered in,Kinnelon, NJ., "As demand ...tory and will be able to provide additional and be...
Other Medicine News:Health News:Depression and Bipolar Results Worth Striving For - A New Recovery Model For Mental Illness 2Health News:Depression and Bipolar Results Worth Striving For - A New Recovery Model For Mental Illness 3Health News:AARP NY Thanks Congress for Keeping Medicare Fair, Overriding White House Veto 2Health News:AARP NY Thanks Congress for Keeping Medicare Fair, Overriding White House Veto 3Health News:SheKnows to Launch Bone Marrow Awareness Campaign and Add 50,000 New Donors 2Health News:Third of Elderly Patients Take Companion to See Doctor 2Health News:Third of Elderly Patients Take Companion to See Doctor 3Health News:Genesis Pharmaceuticals Announces SFDA Approval for Radix Isatidis Dispersible Tablets 2Health News:Genesis Pharmaceuticals Announces SFDA Approval for Radix Isatidis Dispersible Tablets 3
PocketChem UA
Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters with Lumen; SPC-760
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-330A
Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters with Lumen; SPC-780C
Medicine Products: